Valacyclovir and All - a phase IV clinical study of FDA data

Summary:

All is reported as a side effect among people who take Valacyclovir (valacyclovir hydrochloride), especially for people who are male, 20-29 old, also take Revlimid, and have Multiple myeloma.

The phase IV clinical study analyzes which people have All when taking Valacyclovir. It is created by eHealthMe based on reports of 41,259 people who have side effects when taking Valacyclovir from the FDA, and is updated regularly.

What is Valacyclovir?

Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,105 Valacyclovir users. Check the latest studies of Valacyclovir.

What is All?

All (acute lymphoblastic leukaemia) is found to be associated with 433 drugs and 881 conditions by eHealthMe. Check the latest studies of All.

On Sep, 08, 2025

41,259 people reported to have side effects when taking Valacyclovir.
Among them, 21 people (0.05%) have All.

Among these 21 people:

What is the gender of people who have All when taking Valacyclovir? *

female: 35.29 %
male: 64.71 %

What is the age of people who have All when taking Valacyclovir? *

What are other drugs people take besides Valacyclovir? *

What are other side effects people have besides All? *

Venoocclusive Disease (small veins in the liver are obstructed): 4 people, 19.05%
Infection: 4 people, 19.05%
Aplasia (defective development or congenital absence of an organ or tissue): 4 people, 19.05%
Drug Ineffective: 4 people, 19.05%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 4 people, 19.05%
Haemorrhage (bleeding): 4 people, 19.05%
Pain: 2 people, 9.52%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 9.52%
Subdural Haematoma (blood collects between the skull and the surface of the brain): 2 people, 9.52%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 9.52%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 23.81%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 4 people, 19.05%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 4 people, 19.05%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 9.52%
High Blood Pressure: 2 people, 9.52%
Sinus Disorder (disease of sinus): 1 person, 4.76%
Insomnia (sleeplessness): 1 person, 4.76%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 4.76%
Constipation: 1 person, 4.76%
Dry Eyes (lack of adequate tears): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Valacyclovir and have All?

- Check whether All is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Valacyclovir:

Valacyclovir (42,105 reports)

All treatments and more:

All (43,060 reports)

Browse all side effects of Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with All:

All (433 drugs)

Browse all the conditions that are associated with All:

All (881 conditions)

Drugs similar to Valacyclovir and All :

Acyclovir side effect: All

How the study uses the data?

The study uses data from the FDA. It is based on valacyclovir hydrochloride (the active ingredients of Valacyclovir) and Valacyclovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.